As of the March-end quarter, OrbiMed Asia IV Mauritius FVCI Ltd had a 10.88% stake in Marksans Pharma. Previous Post Analyst recommends buying Birlasoft, Power Finance Corporation; selling LIC Next Post IREDA raises ₹2,000 crore through its share sale — LIC gets 50% of the allotment Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
